BioNTech SE - ADR vs Hims and Hers Health Inc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Hims and Hers Health Inc trades at $30.7 (market cap $7.12B). The key difference: BioNTech SE - ADR is far larger — about 3.3× Hims and Hers Health Inc's market cap. Which is the better fit depends on your goals.
| BNTX | HIMS | |
|---|---|---|
Market Cap | $23.31B | $7.12B |
Sector | Health | Health |
52-Week High | $119.34 | $62.76 |
52-Week Low | $83.89 | $14.52 |
Enterprise Value | $6.60B | $7.82B |
Trailing returns across standard periods
Latest headlines on both assets
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →